Medtronic plc, IE00BTN1Y115

Medtronic stock heads for November 24 results after Q1 growth

Published on 11/22/2026 at 17:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Medtronic stock enters the week before its fiscal second-quarter report. The company will discuss results for the period ended October 30.

Medtronic's next investor milestones

  • Medtronic's latest reported quarter ended on Friday, October 30, 2026.
  • First-quarter revenue reached USD 9.756 billion, with organic growth of 13.7 percent.
  • Management raised fiscal 2027 organic revenue growth guidance to 7.25 percent to 7.75 percent in the first quarter.
Medtronic plc, IE00BTN1Y115, Illustration mit AI erstellt.

Medtronic will release its fiscal second-quarter 2027 results on Tuesday, November 24, after the company announced the schedule on November 4. The quarter ended on Friday, October 30, and the release is scheduled for 5:45 a.m. Central Time, followed by a webcast at 6:30 a.m. Central Time, according to the company's announcement.

What the next report will test

The report will give investors the first full-quarter update since Medtronic raised its fiscal 2027 outlook in September. In the first quarter, revenue reached USD 9.756 billion, up 13.7 percent on both a reported and organic basis. Medtronic also raised its fiscal 2027 organic revenue growth guidance to 7.25 percent to 7.75 percent and set diluted non-GAAP earnings-per-share guidance at USD 5.94 to USD 6.00.

The first-quarter performance was broad-based. Cardiovascular revenue rose 18.9 percent organically to USD 3.906 billion, Neuroscience revenue increased 9.3 percent to USD 2.653 billion, and Medical Surgical revenue grew 10.2 percent to USD 2.265 billion. Diabetes revenue rose 14.9 percent organically to USD 829 million. These figures provide the operating backdrop for the second-quarter update, while the company will also report on execution across its newer growth platforms and recent portfolio investments.

Medtronic reported first-quarter GAAP operating profit of USD 1.764 billion and GAAP net income attributable to Medtronic of USD 1.470 billion. Non-GAAP diluted earnings per share were USD 1.45. The company said the first quarter included an extra fiscal week, which benefited organic growth by approximately USD 570 million.

Trading context before the release

Medtronic stock traded at 91.52 euros on Lang & Schwarz at 5:56:34 p.m. CET on Sunday, November 22. The upcoming results are the next scheduled company event with direct relevance for revenue growth, earnings and the fiscal-year outlook.

Medtronic plc

  • Company: Medtronic plc
  • ISIN: IE00BTN1Y115
  • Lang & Schwarz quote: 91.52 euros on Sunday, November 22, 2026, at 5:56:34 p.m. CET

The broader market backdrop is covered in Current market reports.

More news and analyses on Medtronic stock

Disclaimer...
en | IE00BTN1Y115 | MEDTRONIC PLC | boerse | 70544700 | bgmi